π-HuB: the proteomic navigator of the human body

  • Fuchu He
  • , Ruedi Aebersold
  • , Mark S Baker
  • , Xiuwu Bian
  • , Xiaochen Bo
  • , Daniel W Chan
  • , Cheng Chang
  • , Luonan Chen
  • , Xiangmei Chen
  • , Yu-Ju Chen
  • , Heping Cheng
  • , Ben C Collins
  • , Fernando Corrales
  • , Jürgen Cox
  • , Weinan E
  • , Jennifer E Van Eyk
  • , Jia Fan
  • , Pouya Faridi
  • , Daniel Figeys
  • , George Fu Gao
  • Wen Gao, Zu-Hua Gao, Keisuke Goda, Wilson Wen Bin Goh, Dongfeng Gu, Changjiang Guo, Tiannan Guo, Yuezhong He, Albert J R Heck, Henning Hermjakob, Tony Hunter, Narayanan Gopalakrishna Iyer, Ying Jiang, Connie R Jimenez, Lokesh Joshi, Neil L Kelleher, Ming Li, Yang Li, Qingsong Lin, Cui Hua Liu, Fan Liu, Guang-Hui Liu, Yansheng Liu, Zhihua Liu, Teck Yew Low, Ben Lu, Chen Wang, Yan Wang, Jing Yang, Yu Zi Zheng, π-HuB Consortium

Research output: Contribution to journalReview articlepeer-review

20 Citations (Scopus)
293 Downloads (Pure)

Abstract

The human body contains trillions of cells, classified into specific cell types, with diverse morphologies and functions. In addition, cells of the same type can assume different states within an individual's body during their lifetime. Understanding the complexities of the proteome in the context of a human organism and its many potential states is a necessary requirement to understanding human biology, but these complexities can neither be predicted from the genome, nor have they been systematically measurable with available technologies. Recent advances in proteomic technology and computational sciences now provide opportunities to investigate the intricate biology of the human body at unprecedented resolution and scale. Here we introduce a big-science endeavour called π-HuB (proteomic navigator of the human body). The aim of the π-HuB project is to (1) generate and harness multimodality proteomic datasets to enhance our understanding of human biology; (2) facilitate disease risk assessment and diagnosis; (3) uncover new drug targets; (4) optimize appropriate therapeutic strategies; and (5) enable intelligent healthcare, thereby ushering in a new era of proteomics-driven phronesis medicine. This ambitious mission will be implemented by an international collaborative force of multidisciplinary research teams worldwide across academic, industrial and government sectors.

Original languageEnglish
Pages (from-to)322-331
Number of pages10
JournalNature
Volume636
Issue number8042
Early online date11 Dec 2024
DOIs
Publication statusPublished - 12 Dec 2024

Publications and Copyright Policy

This work is licensed under Queen’s Research Publications and Copyright Policy.

Keywords

  • Humans
  • Proteomics
  • Proteome/metabolism
  • Human Body
  • Risk Assessment
  • Precision Medicine/methods
  • Big Data
  • International Cooperation
  • Datasets as Topic

Fingerprint

Dive into the research topics of 'π-HuB: the proteomic navigator of the human body'. Together they form a unique fingerprint.

Cite this